✦ LIBER ✦

Tacrolimus, MMF, steroid, and ALG immunotherapy for high immunological risk renal transplant recipients

✍ Scribed by J Zaltzman; V McAlister; D Russell; P Halloran; D Landsberg; S Busque; A Shoker; A Boucher; J Shapiro; J Tchervenkov; J Peets

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Late Steroid Withdrawal for Renal Transp

✍ M. Loucaidou; R. Borrows; T. Cairns; M. Griffith; N. Hakim; A. Palmer; V. Papalo 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Immunological and nonimmunological risk

✍ W.A Jurewicz 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 63 KB

Observations on the use of sirolimus and

✍ A Lo; M.F Egidi; L.W Gaber; A.O Gaber 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Interleukin-2 receptor antibody does not

✍ WAI H LIM; STEVE J CHADBAN; SCOTT CAMPBELL; HANNAH DENT; GRAEME R RUSS; STEPHEN 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

A prospective 3-yr evaluation of tacroli

✍ Jeffrey S. Zaltzman; Anne Boucher; Stephan Busque; Phillip F. Halloran; David N. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

Incidence and Risk Factors for the Metab

✍ I. Pérez-Flores; A. Sánchez-Fructuoso; N. Calvo; E.F. Valga; A. Barrientos 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 106 KB